Xu Cong Claire
- SEC CIK
- 0002114309
In the past year, 3 open-market sale filings worth $20.4K and no purchases.
Current role at each company
- NBP NovaBridge BiosciencesEVP, Clinical Developmentas of Sep 1, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $20.4K
- 3 filings
- Net
- −$20.4K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Xu Cong Claire as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 (view filing)6:00 PM ET | Aug 31 | 1 day | Xu Cong ClaireEVP, Clinical Development | SSale | −3.28K | $0.79 | −$2.59K | −1.1%304.2K after | |
| Jul 7, 2026 (view filing)7:50 PM ET | Jul 6 | 1 day | Xu Cong ClaireSVP, Clinical Development | SSale | −4.49K | $0.89 | −$3.99K | −1.5%298.1K after | |
| Jun 2, 2026 (view filing) | Jun 1 | 1 day | Xu Cong ClaireSVP, Clinical Development | SSale | −3.49K | $3.94 | −$13.8K | −1.2%290.2K after |